HUP0002876A2 - 5-(2-Etil-2H-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidro-piridin-maleát, e vegyületet tartalmazó gyógyászati készítmény és alkalmazása - Google Patents

5-(2-Etil-2H-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidro-piridin-maleát, e vegyületet tartalmazó gyógyászati készítmény és alkalmazása Download PDF

Info

Publication number
HUP0002876A2
HUP0002876A2 HU0002876A HUP0002876A HUP0002876A2 HU P0002876 A2 HUP0002876 A2 HU P0002876A2 HU 0002876 A HU0002876 A HU 0002876A HU P0002876 A HUP0002876 A HU P0002876A HU P0002876 A2 HUP0002876 A2 HU P0002876A2
Authority
HU
Hungary
Prior art keywords
ethyl
methyl
maleic acid
tetrazol
addition salt
Prior art date
Application number
HU0002876A
Other languages
English (en)
Hungarian (hu)
Inventor
Michael Bech Sommer
Ole Nielsen
Original Assignee
H.Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H.Lundbeck A/S filed Critical H.Lundbeck A/S
Publication of HUP0002876A2 publication Critical patent/HUP0002876A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0002876A 1997-07-01 1998-07-01 5-(2-Etil-2H-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidro-piridin-maleát, e vegyületet tartalmazó gyógyászati készítmény és alkalmazása HUP0002876A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01
PCT/DK1998/000294 WO1999001448A1 (en) 1997-07-01 1998-07-01 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate

Publications (1)

Publication Number Publication Date
HUP0002876A2 true HUP0002876A2 (hu) 2001-06-28

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002876A HUP0002876A2 (hu) 1997-07-01 1998-07-01 5-(2-Etil-2H-tetrazol-5-il)-1-metil-1,2,3,6-tetrahidro-piridin-maleát, e vegyületet tartalmazó gyógyászati készítmény és alkalmazása

Country Status (25)

Country Link
EP (1) EP0994869A1 (ar)
JP (1) JP2002507215A (ar)
KR (1) KR20010014297A (ar)
CN (1) CN1261361A (ar)
AR (1) AR013096A1 (ar)
AU (1) AU735751B2 (ar)
BG (1) BG103933A (ar)
BR (1) BR9810331A (ar)
CA (1) CA2293324A1 (ar)
CO (1) CO4940483A1 (ar)
EA (1) EA200000081A1 (ar)
HU (1) HUP0002876A2 (ar)
IL (1) IL133093A0 (ar)
IS (1) IS5278A (ar)
JO (1) JO2031B1 (ar)
MA (1) MA25138A1 (ar)
NO (1) NO996580D0 (ar)
PE (1) PE116099A1 (ar)
PL (1) PL337184A1 (ar)
SK (1) SK187399A3 (ar)
TN (1) TNSN98120A1 (ar)
TR (1) TR199903283T2 (ar)
UY (2) UY25069A1 (ar)
WO (1) WO1999001448A1 (ar)
ZA (1) ZA985498B (ar)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
CZ287441B6 (en) * 1995-11-06 2000-11-15 Lundbeck & Co As H Pharmaceutical preparation for treating traumatic lesion of brain

Also Published As

Publication number Publication date
BG103933A (en) 2000-07-31
IS5278A (is) 1999-11-30
MA25138A1 (fr) 2001-04-02
JP2002507215A (ja) 2002-03-05
PL337184A1 (en) 2000-08-14
AU8102098A (en) 1999-01-25
JO2031B1 (ar) 1999-05-15
EP0994869A1 (en) 2000-04-26
AR013096A1 (es) 2000-12-13
WO1999001448A1 (en) 1999-01-14
BR9810331A (pt) 2000-09-05
UY25069A1 (es) 1998-12-21
NO996580L (no) 1999-12-30
KR20010014297A (ko) 2001-02-26
SK187399A3 (en) 2000-06-12
PE116099A1 (es) 1999-11-23
TNSN98120A1 (fr) 2005-03-15
TR199903283T2 (xx) 2000-06-21
IL133093A0 (en) 2001-03-19
NO996580D0 (no) 1999-12-30
ZA985498B (en) 1999-01-20
EA200000081A1 (ru) 2000-08-28
CA2293324A1 (en) 1999-01-14
CN1261361A (zh) 2000-07-26
UY25177A1 (es) 2000-12-29
AU735751B2 (en) 2001-07-12
CO4940483A1 (es) 2000-07-24

Similar Documents

Publication Publication Date Title
US5958951A (en) Modified form of the R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
ES2229342T3 (es) Sales de mesilato de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona(=ziprasidona),su preparacion y uso como antagonista de dopamina d2.
EP0811623A1 (de) Xanthinverbindungen mit terminal aminierten Alkinol-Seitenketten
DE69111816T2 (de) Indolederivate und ihre verwendung als serotonin-antagoniste.
US12291528B2 (en) Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions
WO1992017473A1 (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
MXPA03005888A (es) Base libre de amlodipina.
WO1989009767A1 (fr) Composes de carbamoyle-2-pyrrolidinone
US5834495A (en) Crystalline xamoneline tartrate
EP0906309B1 (en) Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
EA009460B1 (ru) Триазольные соединения, полезные в терапии
MXPA03005884A (es) Hemimaleato de amlodipina.
WO1995031431A1 (en) Novel diaminomethylidene derivative
US7335380B2 (en) Amlodipine free base
AU735751B2 (en) 5-(2-ethyl-2H-tetrazol-5-Y1)-1-methyl-1,2,3,6-tetrahydro pyridine maleate
KR20050069976A (ko) 데스로라타딘 헤미푸마레이트의 신규 염 및 다형체
MXPA99011450A (en) 5-(2-ethyl-2h
HK1029342A (en) 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate
CZ477899A3 (cs) 5-(2-ethyI-2H-tetrazol-5-yl)-l-methyl-l,2,3,6- tetrahydropyridinmaleátová adiční sůl
CA2257931C (en) Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
CA2072911A1 (en) Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives
EP1355632B1 (en) Amlodipine free base
JPH04282379A (ja) ４−［４−又は６−（トリフルオロメチル−２−ピリジニル）］−１−ピペラジニルアルキル置換ラクタム
KR100491636B1 (ko) R(-)-n-[4,4-디(3-메틸티엔-2-일)부트-3-엔일)-니페코트산염산염의변형된형태
JP2003511437A (ja) Ｎ−［３−［［２−（３，４−ジメトキシフェニル）エチル］アミノ］プロピル］−４−ニトロベンズアミド塩酸塩の多型相